President Trump receives Regeneron’s “antibody cocktail” treatment
1:57
President Trump receives Regeneron’s “antibody cocktail” treatment
Oct 3, 2020
NBC News
Curious how we make our products? Learn about our Industrial Operations and Product Supply (IOPS) team, which manufactures our medicines for patients worldwide http://bit.ly/2kpbuvc | Regeneron
0:06
Curious how we make our products? Learn about our Industrial Operations and Product Supply (IOPS) team, which manufactures our medicines for patients worldwide http://bit.ly/2kpbuvc | Regeneron
570 viewsFeb 22, 2018
FacebookRegeneron
We're bringing more to the fight against serious diseases. Regeneron was founded in the pursuit of more. | Regeneron
0:06
We're bringing more to the fight against serious diseases. Regeneron was founded in the pursuit of more. | Regeneron
102.4K viewsApr 22, 2025
FacebookRegeneron
From discovery to manufacturing, we're aiming to do more for patients. | Regeneron
0:30
From discovery to manufacturing, we're aiming to do more for patients. | Regeneron
93.7K viewsApr 25, 2025
FacebookRegeneron
Supporting our communities, the next generation of scientific leaders, and helping those who need it most. Learn how our philosophy of doing well by doing good guides our approach. | Regeneron
0:30
Supporting our communities, the next generation of scientific leaders, and helping those who need it most. Learn how our philosophy of doing well by doing good guides our approach. | Regeneron
493.9K views7 months ago
FacebookRegeneron
Supporting our communities, the next generation of scientific leaders, and helping those who need it most. Learn how our philosophy of doing well by doing good guides our approach. | Regeneron
0:06
Supporting our communities, the next generation of scientific leaders, and helping those who need it most. Learn how our philosophy of doing well by doing good guides our approach. | Regeneron
174.7K views10 months ago
FacebookRegeneron
Explore clinical trials to be part of the discovery. | Regeneron
0:31
Explore clinical trials to be part of the discovery. | Regeneron
10.6K views11 months ago
FacebookRegeneron
0:09
What drives a clinical trial investigator? The chance to support progress in science for patients. | Regeneron
34.7K views7 months ago
FacebookRegeneron
0:31
Through clinical trials, we can answer more questions, develop more potentially life-changing medicines, and discover more possibilities. | Regeneron
124.7K viewsNov 20, 2024
FacebookRegeneron
0:31
Bridging today’s limitations with tomorrow’s breakthroughs—one clinical trial at a time. | Regeneron
3.9K views7 months ago
FacebookRegeneron
1:41
What drives a clinical trial investigator? The chance to support progress in science for patients. | Regeneron
23.8K views7 months ago
FacebookRegeneron
1:26
Talk to your doctor to see if a clinical trial is right for you. | Regeneron
222.1K viewsFeb 20, 2025
FacebookRegeneron
0:08
You are part of the future of healthcare. Learn how your involvement can help make a difference. | Regeneron
425.8K views11 months ago
FacebookRegeneron
1:22
In collaboration with Sanofi Genzyme, we work to develop treatments that can have a positive impact on peoples’ lives. This World Arthritis Day hear from Beth, one of our colleagues, about her experience with rheumatoid arthritis. | Regeneron
107.1K viewsOct 12, 2018
FacebookRegeneron
0:11
Our knowledge of the body is ever-changing. Learning about the role of type 2 inflammation has helped us better understand diseases like atopic dermatitis (AD). Working with Sanofi, we’re continuing to research this immune response and its role in chronic inflammatory diseases. | Regeneron
298.7K viewsOct 23, 2020
FacebookRegeneron
0:56
Grounded in excellence and driven by innovation, our Industrial Operations and Product Supply team turns science into medicine. Join our team. | Regeneron
47.1K viewsSep 24, 2023
FacebookRegeneron
Cape Cod Hospital extends Regeneron treatment unit as COVID delta variant ticks up
Oct 2, 2021
capecodtimes.com
1:05
Regeneron is pursuing U.S. approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment https://reut.rs/3daeHgE | Reuters
8.2K viewsApr 12, 2021
FacebookReuters
0:29
Asthma, nasal polyps and atopic dermatitis may be connected. Visit us alongside Sanofi Genzyme at the European Academy of Allergy and Clinical Immunology congress to learn more about the connection between these seemingly unrelated diseases. | Regeneron
10.7K viewsJun 3, 2019
FacebookRegeneron
2:09
World Health Organization approves antibody treatment for certain COVID-19 patients
Nov 8, 2021
Global News
0:15
We’re using CRISPR “knock-in” and “knock-out” technology inside the body to potentially tackle difficult-to-treat genetic conditions. | Regeneron
420.7K viewsOct 26, 2023
FacebookRegeneron
2:25
Timeline: What we know about Regeneron's antibody cocktail that was given to President Trump
Oct 2, 2020
khou.com
2:49
Regeneron Pharmaceuticals will develop and release a “next generation” antibody treatment against the omicron variant early next year after the company said its current antibody cocktail loses potency against the new Covid variant, as the U.S. races to curb a surge of cases across the country. Read More: https://www.forbes.com/sites/annakaplan/2021/12/16/regeneron-developing-new-antibody-covid-cocktail-current-treatment-less-effective-against-omicron/?sh=33969eb0221f&utm_source=FBPAGE&utm_medium
2.4K viewsDec 16, 2021
FacebookForbes
2:13
FDA approves Regeneron’s Covid-19 antibody treatment
Nov 22, 2020
NBC News
1:04
When it comes to COPD, we must act urgently to support the community and help alleviate the disease’s impact on global health systems. Via ongoing research and a deeper understanding of the disease, we’re striving to help address COPD as a global public health concern. | Regeneron
68.5K views8 months ago
FacebookRegeneron
0:28
One thing we’ve learned is that innovation isn’t easy — because real breakthroughs come from challenging everything we think we know. 🤯 At Regeneron, they’ve come from rethinking assumptions, identifying and removing bottlenecks and finding the simplest fundamental truths buried under all the world’s complexity. 🌎 Today’s global health challenges depend on bold, radical innovation. Our CSO George Yancopoulos shares five key principles that guide our scientific curiosity from groundbreaking ide
732 viewsApr 4, 2025
FacebookRegeneron
0:32
How do we turn complex technology challenges into simpler solutions for patients? By designing with intention to remove bottlenecks and build platforms that can adapt across diseases. This approach is guided by our co-founder, President, and Chief Scientific Officer, George D. Yancopoulos, whose five principles of radical innovation shape how we think, design, and build. Created to cut through complexity, our proprietary Veloci-Bi® technology allows for production of bispecific antibodies, which
27.9K views3 months ago
FacebookRegeneron
State closes all monoclonal antibody treatment sites
Jan 24, 2022
wptv.com
0:36
Since our earliest days, we’ve believed that transforming human health takes bold scientific ambition and a deep sense of responsibility. At Regeneron, we pursue breakthrough science and technology with a long-term view, and measure success not just by progress in the lab, but by the impact we have on each patient, colleague and shareholder. Science drives our work, and responsibility fuels it. By staying focused on what matters most to our stakeholders, we’re building a resilient, responsible b
774 viewsApr 30, 2025
FacebookRegeneron
4:21
Why Regeneron's antibody drug will be in short supply
Nov 2, 2020
CNBCMeg Tirrell
See more
You may also want to search